LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma

Clinical trial NCT05876715 · RECRUITING

Trial details

NCT number: NCT05876715
Sponsor: ERLINDA M GORDON
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Soft-tissue Sarcoma

Start date: 2023-06-07
Primary completion: 2026-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.